Founders Financial Securities’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $864K | Sell |
2,130
-144
| -6% | -$58.4K | 0.07% | 263 |
|
|
2025
Q1 | $958K | Buy |
2,274
+37
| +2% | +$15.6K | 0.08% | 228 |
|
|
2024
Q4 | $1.16M | Buy |
2,237
+112
| +5% | +$58.3K | 0.1% | 166 |
|
|
2024
Q3 | $1.31M | Buy |
2,125
+67
| +3% | +$41.4K | 0.12% | 150 |
|
|
2024
Q2 | $1.14M | Buy |
2,058
+19
| +0.9% | +$10.5K | 0.11% | 160 |
|
|
2024
Q1 | $1.19M | Buy |
2,039
+69
| +4% | +$40.1K | 0.12% | 142 |
|
|
2023
Q4 | $1.05M | Buy |
1,970
+301
| +18% | +$160K | 0.12% | 158 |
|
|
2023
Q3 | $845K | Buy |
1,669
+158
| +10% | +$80K | 0.11% | 162 |
|
|
2023
Q2 | $788K | Buy |
1,511
+36
| +2% | +$18.8K | 0.1% | 168 |
|
|
2023
Q1 | $850K | Sell |
1,475
-144
| -9% | -$83K | 0.12% | 151 |
|
|
2022
Q4 | $892K | Buy |
1,619
+35
| +2% | +$19.3K | 0.14% | 148 |
|
|
2022
Q3 | $803K | Buy |
1,584
+102
| +7% | +$51.7K | 0.14% | 136 |
|
|
2022
Q2 | $805K | Sell |
1,482
-72
| -5% | -$39.1K | 0.16% | 119 |
|
|
2022
Q1 | $918K | Sell |
1,554
-82
| -5% | -$48.4K | 0.16% | 119 |
|
|
2021
Q4 | $1.09M | Sell |
1,636
-79
| -5% | -$52.7K | 0.2% | 102 |
|
|
2021
Q3 | $980K | Buy |
1,715
+79
| +5% | +$45.1K | 0.2% | 104 |
|
|
2021
Q2 | $825K | Buy |
1,636
+38
| +2% | +$19.2K | 0.16% | 129 |
|
|
2021
Q1 | $729K | Buy |
1,598
+225
| +16% | +$103K | 0.17% | 125 |
|
|
2020
Q4 | $640K | Buy |
1,373
+300
| +28% | +$140K | 0.15% | 109 |
|
|
2020
Q3 | $474K | Buy |
1,073
+84
| +8% | +$37.1K | 0.15% | 94 |
|
|
2020
Q2 | $360K | Buy |
989
+151
| +18% | +$55K | 0.12% | 121 |
|
|
2020
Q1 | $238K | Buy |
838
+33
| +4% | +$9.37K | 0.09% | 114 |
|
|
2019
Q4 | $262K | Buy |
805
+60
| +8% | +$19.5K | 0.09% | 113 |
|
|
2019
Q3 | $217K | Buy |
+745
| New | +$217K | 0.07% | 123 |
|